Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain

VALUE IN HEALTH(2016)

引用 3|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要